Ceapro Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights Biotech Investing
XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte Biotech Investing
Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program Pharmaceutical Investing
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule Pharmaceutical Investing
PreveCeutical Converts Acidic Phytocannabinoids to Neutral Form and Doubles Contents of Fingerprinted Cannabis Extract Library Cannabis Investing News
GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia Biotech Investing
TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar Pharmaceutical Investing
